Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · USANA HEALTH SCIENCES INC (USNA)

USANA cuts fiscal 2026 net sales and Adjusted EBITDA outlook as Q3 net sales fall 4%

Mixed Impact 4 of 5 earnings Written later

USANA reported third-quarter 2026 net sales of $206 million, down from $214 million a year earlier, while its net loss narrowed to $(5.6) million from $(6.5) million. The company lowered its fiscal 2026 outlook, now expecting consolidated net sales approaching $900 million (previously $910 million) and Adjusted EBITDA of $77 million (previously $80.5 million, as corrected), and it also expects a larger full-year net loss of $(16) million, versus $(11) million previously.

Key points

  • Q3 2026 net sales of $206 million, down 4% year over year; Adjusted EBITDA of $12.1 million, down 13%
  • Net loss of $(5.6) million and diluted EPS of $(0.30), compared with $(0.36) a year earlier
  • Fiscal 2026 outlook: net sales approaching $900 million (from $910 million); net loss $(16) million (from $(11) million); diluted EPS $(0.90) (from $(0.61))
  • Company corrected prior Adjusted EBITDA: second quarter 2026 reduced from $27.8 million to $21.7 million; cash and equivalents $179 million with no debt

The filing

CompanyUSANA HEALTH SCIENCES INC (USNA)
Form8-K, current report
Filed with the SECNov 3, 2026, 4:10 PM ET
Accession number0000896264-26-000064

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:28 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 03, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.